Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-046622)

Filing Details

Accession Number:: 0001209191-20-046622
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-13 16:52:44
Reporting Period:: 2020-08-11

Accepted Time:: 2020-08-13 16:52:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651431	Checkmate Pharmaceuticals Inc.	CMPI	()	G7

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1388325	A/S Holdings Novo	Tuborg Havnevej 19 Hellerup G7 2900		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-11	1,670,100	$0.00	1,670,100	No	4	C	Direct
Common Stock	Acquisiton	2020-08-11	500,000	$15.00	2,170,100	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	SERIES C REDEEMABLE CONVERTIBLE PREFERRED STOCK	Disposition	2020-08-11	12,487,512	$0.00	1,670,100	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The Series C Redeemable Convertible Preferred Stock automatically converted on a 7.4771-for-1 basis into the number of shares of common stock as shown in Column 7 upon the completion of the Issuer's initial public offering without payment of further consideration. These shares have no expiration date
Represents a purchase from the underwriters in the Issuer's initial public offering.